Advances in therapy for the prevention of HIV transmission from mother to child (Q39234019)

10 September 2017

Advances in therapy for the prevention of HIV transmission from mother to child (English)

1 reference

10 September 2017

0 references

prevention of HIV/AIDS

0 references

6

Christian Höcht

1 reference

10 September 2017

Marcela A Moretton

1

1 reference

10 September 2017

Facundo Bertera

2

1 reference

10 September 2017

Eduardo Lagomarsino

3

1 reference

10 September 2017

Jennifer Riedel

4

1 reference

10 September 2017

Diego A Chiappetta

5

1 reference

10 September 2017

language of work or name

English

0 references

publication date

11 April 2017

1 reference

Expert Opinion on Pharmacotherapy

10 September 2017

1 reference

10 September 2017

18

1 reference

10 September 2017

657-666

1 reference

10 September 2017

7

1 reference

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.

10 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Management of HIV Infection during Pregnancy in the United States: Updated Evidence-Based Recommendations and Future Potential Practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Mother and child both matter: reconceptualizing the prevention of mother-to-child transmission care continuum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Challenges in the Elimination of Pediatric HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Antiretroviral drugs to prevent breastfeeding HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

HIV-free survival at 12-24 months in breastfed infants of HIV-infected women on antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Three postpartum antiretroviral regimens to prevent intrapartum HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Long-acting antiviral agents for HIV treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Long-acting injectable antiretrovirals for HIV treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

Improving HIV pre-exposure prophylaxis for infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14656566.2017.1316369

10.1080/14656566.2017.1316369

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference